Clinical Impact of Plasma and Tissue Next‐Generation Sequencing in Advanced Non‐Small Cell Lung Cancer: A Real‐World Experience

Lignende værker

• Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment
  af: Stefano Frega, et al.
  Udgivet: (2020-02-01)
• Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment
  af: Frega, Stefano, et al.
  Udgivet: (2020)
• Peripheral Blood Markers Identify Risk of Immune‐Related Toxicity in Advanced Non‐Small Cell Lung Cancer Treated with Immune‐Checkpoint Inhibitors
  af: Pavan, Alberto, et al.
  Udgivet: (2019)
• Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report
  af: Ferro, Alessandra, et al.
  Udgivet: (2021)
• Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome
  af: Pavan, Alberto, et al.
  Udgivet: (2021)